TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+13.24%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$482M
AUM Growth
+$482M
(+2.4%)
Cap. Flow
-$33.3M
Cap. Flow
% of AUM
-6.92%
Top 10 Holdings %
Top 10 Hldgs %
50.55%
Holding
78
New
26
Increased
9
Reduced
18
Closed
10
Top Buys
| 1 |
PDCO
Patterson Companies, Inc.
PDCO
|
$24.6M |
| 2 |
CVS Health
CVS
|
$16.9M |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
$10.7M |
| 4 |
Bioventus
BVS
|
$10.3M |
| 5 |
Henry Schein
HSIC
|
$7.62M |
Top Sells
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
$15.3M |
| 2 |
Perrigo
PRGO
|
$14.2M |
| 3 |
United Therapeutics
UTHR
|
$13.9M |
| 4 |
Pacira BioSciences
PCRX
|
$13M |
| 5 |
AtriCure
ATRC
|
$10.9M |
Sector Composition
| 1 | Healthcare | 86.27% |
| 2 | Consumer Staples | 4.33% |
| 3 | Technology | 4.31% |
| 4 | Consumer Discretionary | 0.47% |
| 5 | Industrials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pacira BioSciences
PCRX
$1.2B
| $38.6M | 7.91% | 550,000 -185,000 | -25% | -$13M |
|
2
Medtronic
MDT
$119B
| $35.4M | 7.27% | 300,000 -75,000 | -20% | -$8.86M |
|
3
Rigel Pharmaceuticals
RIGL
$697M
| $28.6M | 5.86% | 8,350,000 +900,000 | +12% | +$3.08M |
|
|
PDCO
4
DELISTED
Patterson Companies, Inc.
PDCO
| $24.6M | 5.05% | +770,000 | New | +$24.6M |
|
5
Turning Point Brands
TPB
$1.79B
| $20.9M | 4.28% | 400,000 +30,000 | +8% | +$1.57M |
|
6
Hologic
HOLX
$14.9B
| $20.5M | 4.2% | 275,000 | – | – |
|
7
Lantheus
LNTH
$3.73B
| $19.8M | 4.05% | 925,000 -25,000 | -3% | -$534K |
|
8
Quest Diagnostics
DGX
$20.3B
| $19.3M | 3.95% | 150,000 -15,000 | -9% | -$1.93M |
|
9
Labcorp
LH
$23.1B
| $19.1M | 3.92% | 75,000 -25,000 | -25% | -$6.38M |
|
|
10
CVS Health
CVS
$92.8B
| $16.9M | 3.47% | +225,000 | New | +$16.9M |
|
|
11
United Therapeutics
UTHR
$13.8B
| $16.7M | 3.43% | 100,000 -83,000 | -45% | -$13.9M |
|
|
LMNX
12
DELISTED
Luminex Corp
LMNX
| $15.3M | 3.13% | 478,327 +228,327 | +91% | +$7.28M |
|
13
RadNet
RDNT
$5.52B
| $14.9M | 3.06% | 685,000 +35,000 | +5% | +$761K |
|
14
ICU Medical
ICUI
$3.15B
| $14.4M | 2.95% | 70,000 -3,000 | -4% | -$616K |
|
|
MDRX
15
DELISTED
Veradigm Inc. Common Stock
MDRX
| $13.1M | 2.69% | 875,000 -625,000 | -42% | -$9.38M |
|
|
16
AtriCure
ATRC
$1.84B
| $13.1M | 2.69% | 200,000 -166,400 | -45% | -$10.9M |
|
17
Integer Holdings
ITGR
$3.78B
| $12M | 2.45% | 129,800 +55,800 | +75% | +$5.14M |
|
|
VRAY
18
DELISTED
ViewRay, Inc.
VRAY
| $10.7M | 2.19% | +2,450,000 | New | +$10.7M |
|
|
19
Bioventus
BVS
$495M
| $10.3M | 2.12% | +675,000 | New | +$10.3M |
|
|
STRM
20
DELISTED
Streamline Health Solutions
STRM
| $10.1M | 2.07% | 4,930,882 +625,000 | +15% | +$1.28M |
|
21
Plexus
PLXS
$3.7B
| $10.1M | 2.07% | 110,000 +10,000 | +10% | +$918K |
|
|
NUAN
22
DELISTED
Nuance Communications, Inc.
NUAN
| $9.82M | 2.01% | 225,000 -350,000 | -61% | -$15.3M |
|
23
SI-BONE Inc
SIBN
$719M
| $8.75M | 1.79% | 275,000 -110,000 | -29% | -$3.5M |
|
|
24
Henry Schein
HSIC
$8.44B
| $7.62M | 1.56% | +110,000 | New | +$7.62M |
|
25
AngioDynamics
ANGO
$417M
| $7.61M | 1.56% | 325,000 -35,000 | -10% | -$819K |
|